Interview John Tomtishen, Global Head of Cell Therapy, Catalent
Read the full article3h agoen
You might also wanna read
Cette thérapie permet de transformer les cellules immunitaires en arme contre le cancer grâce à une injection chez la souris
Une avancée majeure en thérapie génique permet de reprogrammer les cellules immunitaires directement dans le corps pour cibler les tumeurs,
Science et vie·10h ago
OHSU advances massive leap in medical science with cellular therapies
Patients are benefiting from CAR-T to treat neurodegenerative diseases, cancer, lupus and other autoimmune conditions.
Oregon Health & Sciences University·13d ago
Manufacturing and regulatory hurdles threaten cell and gene therapy progress
What I’ve been reading (and watching) week ending 14 June 2026 Manufacturing requirements are killing cell and gene therapy Until manufactur
medium.com·25d agoUntitled
Hall’s research stemmed from a fortuitous decision he made in 1991 to investigate the action of rapamycin in yeast. This led to his discover
laskerfoundation.org·27d ago
How excessive FDA manufacturing requirements are bottlenecking cell and gene therapy companies
Some of the most promising drugs are bottlenecked by a "boring" but incredibly important problem
writingruxandrabio.com·6d agoRedirecting
Here is the link to our new research article that was just published in Cell Reports Medicine ( Us…
doi.org·20d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.